RPRX @ 9.60 UP 49% >>> $41. Target: Brean Capital Maintains Buy On Repros Therapeutics Following Analyst Day http://www.smarteranalyst.com/2014/11/03/brean-capital-maintains-buy-on-repros-therapeutics-following-analyst-day/